Open AccessHuman erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.
Author(s) -
Louise Dubois,
Liza Löf,
Anders Larsson,
Kjell Hultenby,
Anders Waldenström,
Masood KamaliMoghaddam,
Gunnar Ronquist,
G. Ronquist
Publication year - 2018
Publication title -
cancer research frontiers
Language(s) - English
Resource type - Journals
ISSN - 2328-5249
DOI - 10.17980/2018.13
Subject(s) - doxorubicin , pharmacology , anticancer drug , chemistry , medicine , drug , chemotherapy
Human erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom